questionText: To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that NICE guidance on GLP-1 medications for obesity is implemented consistently across Integrated Care Boards; and if he will review the methodology used to allocate funding for GLP-1 medications and specialist weight management services so that it reflects the true number of clinically eligible patients in each ICB and reduces regional variation in access.
answerText: Integrated care boards (ICBs) are legally required to make funding available for medicines recommended by the National Institute for Health and Care Excellence (NICE) in line with NICE guidance and the NICE Funding Variation for tirzepatide. NHS England i...
heading: Obesity: Health Services